Regul Medical

Manufacturing · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Regul Medical

Regul Medical is a pharmaceutical company founded in 2007, specializing in the development of innovative products based on plant regulatory peptides. Their flagship product, GA-40, is an immunotropic preparation approved for use in the treatment of carcinoma patients, showcasing anti-tumor, nephroprotective, and anti-inflammatory effects. The company aims to improve the quality of life and life expectancy of patients worldwide through their unique peptide-based therapies. With a commitment to research and collaboration, Regul Medical serves clients in over 60 countries, providing solutions for serious health complications.Explore more
Popular SearchesRegul MedicalSIC Code 28,283NAICS Code 32,325Show more

Is Regul Medical your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Regul Medical

Compare insights from companies similar to Regul Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Regul Medical

<$5M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2014
BB
Barbara BarbeauChief Regulatory Officer
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2004
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2012
JS
Josephine SungScientist and Owner
Illustration of an envelope

Regul Medical Tech Stack

A closer look at the technologies used by Regul Medical

Top Manufacturing Companies

Frequently Asked Questions Regarding Regul Medical

What is Regul Medical's official website?
Regul Medical's official website is www.regulmedical.com
What is Regul Medical's Revenue?
Regul Medical's revenue is <$5 Million
What is Regul Medical's SIC code?
Regul Medical's SIC: 28,283
What is Regul Medical's NAICS code?
Regul Medical's NAICS: 32,325
How many employees does Regul Medical have?
Regul Medical has 1-10 employees
What industry does Regul Medical belong to?
Regul Medical is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Regul Medical competition?
Regul Medical top competitors include: Oncorx Pharmaceuticals, Bessor Pharma, Pharmanest, Pharma Models
What technology does Regul Medical use?
Some of the popular technologies that Regul Medical uses are: Google Universal Analytics, YouTube, Google Analytics, JivoChat
What does Regul Medical do?

Regul Medical is a pharmaceutical company founded in 2007, specializing in the development of innovative products based on plant regulatory peptides. Their flagship product, GA-40, is an immunotropic preparation approved for use in the treatment of carcinoma patients, showcasing anti-tumor, nephroprotective, and anti-inflammatory effects. The compa... ny aims to improve the quality of life and life expectancy of patients worldwide through their unique peptide-based therapies. With a commitment to research and collaboration, Regul Medical serves clients in over 60 countries, providing solutions for serious health complications.Read More

Is Regul Medical a public company?
Regul Medical is private company therefore does not currently have an official ticker symbol
See more information about Regul Medical

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.